11Dec/13

Veloxis Pharmaceuticals Announces Initiation of ASERTAA Study of ENVARSUS … – GlobeNewswire (press release)

Veloxis Pharmaceuticals Announces Initiation of ASERTAA Study of ENVARSUS …
GlobeNewswire (press release)
Veloxis Pharmaceuticals A/S (OMX: VELO) today announced dosing of the first patient in ASERTAA (A Study of Extended Release Tacrolimus in African-Americans) Phase IIIb study of ENVARSUS® (formerly LCP Tacro™) in kidney transplant recipients.

and more »

11Dec/13

Global Kidney Transplantation Clinical Trials Review 2013: Worldwide Industry … – DigitalJournal.com

Global Kidney Transplantation Clinical Trials Review 2013: Worldwide Industry …
DigitalJournal.com
Clinical trial report, “Kidney Transplantation Global Clinical Trials Review, H2, 2013″ provides data on the Kidney Transplantation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Kidney …

and more »

11Dec/13

Global Kidney Transplantation Clinical Trials Review 2013: Worldwide Industry … – PR Web (press release)

Global Kidney Transplantation Clinical Trials Review 2013: Worldwide Industry …
PR Web (press release)
Clinical trial report, “Kidney Transplantation Global Clinical Trials Review, H2, 2013″ provides data on the Kidney Transplantation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Kidney …

and more »

10Dec/13

Latest Data Further Support Ibrutinib's Efficacy in CLL – OncLive


OncLive

Latest Data Further Support Ibrutinib’s Efficacy in CLL
OncLive
Combining ibrutinib with the chemoimmunotherapy regimen of bendamustine (Treanda) plus rituximab (Rituxan) demonstrated a high level of activity and was tolerable for patients with relapsed or refractory CLL.1 Presenting the final results of the 30 …
Pharmacyclics Announces Data Presentations for Ibrutinib in B-Cell MalignanciesMarketWatch

all 34 news articles »